![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Department of Chemistry and Biochemistry, University of California, San Diego, CA
Although the need for selenium in human and animal nutrition is well recognized, the question concerning the proper form of selenium for supplemental use is still being debated. Ideally, selenium should be supplemented in the form in which it occurs naturally in foods. Because the L-isomer of selenomethionine (Se-met) is a major natural food-form of selenium, synthetic L-Se-met or enriched food sources thereof such as selenium yeast are appropriate supplemental forms of Se for humans; for animals, DL-Se-met is acceptable. Ingested Se-met is either metabolized directly to reactive forms of selenium or stored in place of methionine in body proteins. Se-met metabolism is closely linked to protein turnover. At constant intakes in the nutritional range, tissue Se levels increase until a steady state is established, preventing the build-up to toxic levels.
KEY WORDS: • selenium • selenomethionine • selenium yeast • selenoproteins • selenium metabolism • toxicity
This article has been cited by other articles:
|
|
 |
|
  R. D. Mateo, J. E. Spallholz, R. Elder, I. Yoon, and S. W. Kim Efficacy of dietary selenium sources on growth and carcass characteristics of growing-finishing pigs fed diets containing high endogenous selenium J Anim Sci, May 1, 2007; 85(5): 1177 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Yoon and E. McMillan Comparative effects of organic and inorganic selenium on selenium transfer from sows to nursing pigs J Anim Sci, July 1, 2006; 84(7): 1729 - 1733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Lippman, P. J. Goodman, E. A. Klein, H. L. Parnes, I. M. Thompson, A. R. Kristal, R. M. Santella, J. L. Probstfield, C. M. Moinpour, D. Albanes, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT) J Natl Cancer Inst, January 19, 2005; 97(2): 94 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ramos, A. N. Lane, D. Hollingworth, and T. W.-M. Fan Secondary structure and stability of the selenocysteine insertion sequences (SECIS) for human thioredoxin reductase and glutathione peroxidase Nucleic Acids Res., March 16, 2004; 32(5): 1746 - 1755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Frank, D. J. Roe, H-H. S. Chow, J. M. Guillen, K. Choquette, D. Gracie, J. Francis, A. Fish, and D. S. Alberts Effects of a High-Selenium Yeast Supplement on Celecoxib Plasma Levels: A Randomized Phase II Trial Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 299 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Whanger Selenocompounds in Plants and Animals and their Biological Significance J. Am. Coll. Nutr., June 1, 2002; 21(3): 223 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Venkateswaran, L. H. Klotz, and N. E. Fleshner Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Human Prostate Carcinoma Cell Lines Cancer Res., May 1, 2002; 62(9): 2540 - 2545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gromer and J. H. Gross Methylseleninate Is a Substrate Rather Than an Inhibitor of Mammalian Thioredoxin Reductase. IMPLICATIONS FOR THE ANTITUMOR EFFECTS OF SELENIUM J. Biol. Chem., March 15, 2002; 277(12): 9701 - 9706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. N. Schrauzer Nutritional Selenium Supplements: Product Types, Quality, and Safety J. Am. Coll. Nutr., February 1, 2001; 20(1): 1 - 4. [Abstract] [Full Text] [PDF]
|
|
